Viemed Healthcare Stock (NASDAQ:VMD)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$10.13

52W Range

$5.93 - $10.46

50D Avg

$9.64

200D Avg

$8.00

Market Cap

$399.47M

Avg Vol (3M)

$272.93K

Beta

1.13

Div Yield

-

VMD Company Profile


Viemed Healthcare, Inc., through its operating subsidiaries, delivers essential in-home durable medical equipment (DME) and specialized post-acute respiratory healthcare services to patients throughout the United States. The company's core focus is on respiratory disease management, particularly for chronic obstructive pulmonary disease (COPD). This encompasses a range of solutions such as non-invasive ventilation (NIV), percussion vests, and various other therapeutic interventions. They supply both invasive and non-invasive ventilation equipment and related accessories specifically for individuals with COPD. Viemed facilitates access to necessary equipment through leasing and sales. Their offerings include non-invasive and invasive ventilators, positive airway pressure (PAP) machines, percussion vests, oxygen concentrator units, and other vital small respiratory devices. In addition to DME, they also provide patient medical services. Beyond respiratory care, Viemed extends its services to include neuromuscular care and oxygen therapy. They are also a key provider in sleep apnea management, supplying equipment like PAP, automatic continuous positive airway pressure (APAP), and bi-level positive airway pressure (BiPAP) machines. Furthermore, the company conducts convenient in-home sleep apnea testing. Established in 2006, Viemed Healthcare, Inc. maintains its headquarters in Lafayette, Louisiana.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,222

IPO Date

Aug 09, 2019

Website

VMD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Service$24.89M$20.13M$10.66M
Equipment Sales$50.25M$30.90M$25.77M
COVID-19 Response Sales---

Fiscal year ends in Dec 25 | Currency in USD

VMD Financial Summary


Dec 25Dec 24Dec 23
Revenue$270.28M$224.26M$183.01M
Operating Income$22.95M$17.90M$14.33M
Net Income$14.93M$11.27M$10.24M
EBITDA$21.63M$42.31M$36.68M
Basic EPS$0.38$0.29$0.27
Diluted EPS$0.37$0.28$0.25

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 11:00 AM
Q4 25Mar 05, 26 | 11:00 AM
Q3 25Nov 07, 25 | 11:00 AM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health, Inc.
SENSSenseonics Holdings, Inc.
QTRXQuanterix Corporation
INGNInogen, Inc.
SGHTSight Sciences, Inc.
MASS908 Devices Inc.
NNOXNano-X Imaging Ltd.
OMOutset Medical, Inc.
CVRXCVRx, Inc.